Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Levers Health vs Peak Wellness

Levers Health
Graded #468

Lower grade

vs+8.5
Peak Wellness
Graded #285

Higher grade

The verdict

Peak Wellness takes it — 61.8/100 to 53.3/100.

Peak Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth wellness provider offering compounded GLP-1 medications with promotional first-month pricing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePeak Wellness +8
34
42
Dose & formulationPeak Wellness +10
54
64
Clinical oversightPeak Wellness +11
71
82
Labs & monitoringEven
53
53
FulfillmentPeak Wellness +19
62
81
Contract termsEven
55
55
Levers Health · left barPeak Wellness · right bar

The numbers

MetricLevers HealthPeak Wellness
WeighScore53.3/10061.8/100
GradeCC
Scorecard rank#468#285
Semaglutide$247/mo (1.25 mg dose, compounded)$249/mo (starting dose, compounded)
Tirzepatide$296/mo (5 mg dose, compounded)$349/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Levers Health

Graded #468 · C

Strengths

  • Named LLC entity
  • Microdose GLP-1 option marketed for longevity
  • Both semaglutide and tirzepatide available

Where it loses points

  • No LegitScript or PCAB accreditation
  • No physical address disclosed
  • State availability not disclosed
  • FAQ and terms pages return 404
  • Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)
Peak Wellness

Graded #285 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard